PROGRAM LEADERS---CANCER PREVENTION

癌症预防和人口科学（CPPS）计划的目标是通过开展创新的多学科癌症预防和人口科学研究来减少癌症的发病率和影响。CPPS计划有31名来自贝勒大学多个部门的研究成员，包括医学，儿科，外科，泌尿科，精神病学和神经科学。其中包括5名新成员，他们的招募是由癌症中心促进的;此外，6名贝勒研究人员在尼古丁依赖的生物行为方面加入了CPPS。该计划去年获得了NCI的4，561，452美元的支持，总共获得了10，035，029美元的同行评审资金。该项目的成员在同行评审期刊上发表了300多篇癌症相关的手稿，其中29%是项目内合作，12%是项目间合作。我们的计划在概念上分为两个广泛的主题领域：（1）癌症流行病学和遗传学：CPPS研究人员进行研究，以检查儿童和成人癌症的病因，并研究基因和基因的贡献。 环境相互作用对它们的病因学的影响;并确定导致遗传性癌症易感性的综合征的临床和分子特征。其他CPPS研究人员评估癌症的结果，特别是为了解决健康差距和不公平的访问，治疗和生存。主要成就包括分析几种消化道和肝癌的长期趋势和风险因素，鉴定与儿童和成人肿瘤风险相关的遗传多态性，以及Barrett食管和肝硬化等癌前病变，（2）生物行为研究和 癌症预防：这一主题的重点是儿童肥胖和体育活动，其中研究人员研究儿童和青少年肥胖和体育活动的决定因素，并评估文化上适当的干预措施;尼古丁依赖，其中研究人员在动物模型和人类研究中研究成瘾行为的遗传学，并评估新的 戒烟干预;化学预防研究，在动物和人体试验中测试新的预防剂。在这一主题的主要成就包括干预方案的发展，以改善儿童饮食和运动，以打击儿童肥胖，遗传学的尼古丁依赖的作用，通过研究尼古丁受体，和乳腺癌预防临床试验的进行。

The goal of the Cancer Prevention and Population Sciences (CPPS) Program is to reduce the incidence and impact of cancer by conducting innovative multidisciplinary cancer prevention and population sciences research. The CPPS Program has 31 research members from a multiple Departments at Baylor, including Medicine, Pediatrics, Surgery, Urology, Psychiatry, and Neuroscience. These include 5 new members whose recruitment to Baylor was facilitated by the Cancer Center; in addition, 6 Baylor investigators in the biobehavioral aspects of nicotine dependence have joined CPPS. The program had $4,561,452 support from the NCI last year and overall received $10,035,029 in peer reviewed funding. Members of the program published over 300 cancer related manuscripts in peer-reviewed journals of which 29% were intraprogrammatic collaborations and 12% interprogrammatic. Our program is conceptually organized into two broad thematic areas: (1) Cancer Epidemiology and Genetics: CPPS Investigators conduct studies to examine the etiology of childhood and adulthood cancers, and to study the contribution of gene and gene environment interactions to their etiology; and to identify the clinical and molecular characteristics of syndromes that result in hereditary predisposition to cancers. Other CPPS investigators evaluate the cancer outcomes especially to address health disparities and inequities in access, treatment, and survival. Major accomplishments include analyses of secular trends and risk factors for several digestive and liver cancers, identification of genetic polymorphisms that are associated with risk of childhood and adult tumors as well as for premalignant lesions such as Barrett's esophagus and liver cirrhosis, (2) Biobehavioral Research and Cancer Prevention: This theme is focused on Childhood Obesity and Physical Activity, in which investigators study the determinants of obesity and physical activity in children and adolescents, and evaluate culturally appropriate interventions; Nicotine Dependence in which investigators examine the genetics of addictive behavior, in both animal models and human studies, and to evaluate novel interventions for smoking cessation; and Chemoprevention research to test novel prevention agents in animals and in human trials. Major accomplishments in this theme include the development of interventional programs to improve childhood diet and exercise to combat childhood obesity, the role of genetics in nicotine dependence through study of nicotinic receptors, and the conduct of breast cancer prevention clinical trials.